Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 3
1962 3
1963 18
1964 43
1965 55
1966 57
1967 91
1968 93
1969 112
1970 120
1971 120
1972 103
1973 96
1974 133
1975 103
1976 104
1977 114
1978 114
1979 139
1980 151
1981 173
1982 218
1983 202
1984 226
1985 226
1986 232
1987 238
1988 235
1989 234
1990 279
1991 249
1992 232
1993 227
1994 228
1995 187
1996 186
1997 175
1998 146
1999 139
2000 153
2001 131
2002 144
2003 142
2004 168
2005 144
2006 154
2007 151
2008 167
2009 117
2010 121
2011 115
2012 102
2013 99
2014 90
2015 71
2016 72
2017 81
2018 62
2019 42
2020 57
2021 51
2022 41
2023 42
2024 50

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,038 results

Results by year

Filters applied: . Clear all
Page 1
Desipramine: an overview.
Janowsky DS, Byerley B. Janowsky DS, et al. J Clin Psychiatry. 1984 Oct;45(10 Pt 2):3-9. J Clin Psychiatry. 1984. PMID: 6384207 Review.
It is proposed that factors including a long "track record," perceived lack of anticholinergic effects, suggestions of earlier onset of action, and the concept of noradrenergic specificity have contributed to the widespread clinical use of desipramine. Recent studies beari …
It is proposed that factors including a long "track record," perceived lack of anticholinergic effects, suggestions of earlier onset of acti …
Desipramine.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1965 May 21;7(11):44. Med Lett Drugs Ther. 1965. PMID: 5826748 No abstract available.
Clinical pharmacokinetics of imipramine and desipramine.
Sallee FR, Pollock BG. Sallee FR, et al. Clin Pharmacokinet. 1990 May;18(5):346-64. doi: 10.2165/00003088-199018050-00002. Clin Pharmacokinet. 1990. PMID: 2185906 Review.
In at least a third of the population, nonlinear pharmacokinetics of desipramine may be observed at steady-state plasma concentrations above 150 micrograms/L. These nonlinear changes in desipramine pharmacokinetics are not associated with age or sex, but are associa …
In at least a third of the population, nonlinear pharmacokinetics of desipramine may be observed at steady-state plasma concentration …
Pharmacokinetics of accumulation.
van Rossum JM. van Rossum JM. J Pharm Sci. 1968 Dec;57(12):2162-5. doi: 10.1002/jps.2600571230. J Pharm Sci. 1968. PMID: 5708363 No abstract available.
Imipramine and tinnitus.
Tandon R, Grunhaus L, Greden JF. Tandon R, et al. J Clin Psychiatry. 1987 Mar;48(3):109-11. J Clin Psychiatry. 1987. PMID: 3818550
Each developed tinnitus in the second or third week of treatment with imipramine at daily dosages of 150-250 mg and at combined plasma imipramine-desipramine levels between 200-450 ng/ml. In each patient, tinnitus subsided spontaneously within 2-4 weeks of onset without an …
Each developed tinnitus in the second or third week of treatment with imipramine at daily dosages of 150-250 mg and at combined plasma imipr …
Desipramine side-effect.
Mosholder A, Bates C. Mosholder A, et al. J Am Acad Child Adolesc Psychiatry. 1991 Nov;30(6):1026. doi: 10.1097/00004583-199111000-00030. J Am Acad Child Adolesc Psychiatry. 1991. PMID: 1757433 No abstract available.
Desipramine relieves postherpetic neuralgia.
Kishore-Kumar R, Max MB, Schafer SC, Gaughan AM, Smoller B, Gracely RH, Dubner R. Kishore-Kumar R, et al. Clin Pharmacol Ther. 1990 Mar;47(3):305-12. doi: 10.1038/clpt.1990.33. Clin Pharmacol Ther. 1990. PMID: 2178851 Clinical Trial.
In a randomized double-blind crossover design, we gave 26 postherpetic neuralgia patients 6 weeks of treatment with desipramine (mean dose, 167 mg/day) and placebo. Nineteen patients completed both treatments; 12 reported at least moderate relief with desipramine an …
In a randomized double-blind crossover design, we gave 26 postherpetic neuralgia patients 6 weeks of treatment with desipramine (mean …
Stimulatory effect of fluoxetine and desipramine, but not mirtazapine on C26 colon carcinoma hepatic metastases formation: association with cytokines.
Kubera M, Arteta B, Grygier B, Curzytek K, Malicki S, Maes M. Kubera M, et al. Front Immunol. 2023 Jun 20;14:1160977. doi: 10.3389/fimmu.2023.1160977. eCollection 2023. Front Immunol. 2023. PMID: 37409130 Free PMC article.
In this study, we investigated the effects of fluoxetine, desipramine, and mirtazapine on the liver metastasis of murine C26 colon carcinoma (cc). ...The current study demonstrates that the stimulatory effect of desipramine and fluoxetine, but not mirtazapine, on ex …
In this study, we investigated the effects of fluoxetine, desipramine, and mirtazapine on the liver metastasis of murine C26 colon ca …
A systematic review of the efficacy and safety of desipramine for treating ADHD.
Ghanizadeh A. Ghanizadeh A. Curr Drug Saf. 2013 Jul;8(3):169-74. doi: 10.2174/15748863113089990029. Curr Drug Saf. 2013. PMID: 23914752 Review.
This review article systematically and critically summarizes the current evidence regarding desipramine for treating children and adolescents with attention deficit hyperactivity disorder (ADHD). ...Out of 267 titles under the study, thirty three articles mentioned desi …
This review article systematically and critically summarizes the current evidence regarding desipramine for treating children and ado …
Desipramine and the EKG.
Smith RH. Smith RH. J Am Acad Child Adolesc Psychiatry. 1992 May;31(3):564-5. J Am Acad Child Adolesc Psychiatry. 1992. PMID: 1592794 No abstract available.
8,038 results